PRESIDENT AND CFO · Alto Neuroscience, Inc. · Common Stock
Side
SELL
Value
$597K
Shares
23.2K
Price
$25.78
Executed
Sep 30, 2026
Disclosed
Oct 1, 2026
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Sep 30 executedOct 1, 2026 disclosed
ANRO · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+4 / 15
1 prior trade recorded in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Smith Nicholas Conrad filed this Form 4 reporting a open-market sale of ANRO on Sep 30, 2026. It became public on Oct 1, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
PRESIDENT AND CFO
Smith Nicholas Conradcik:0002009130
Issuer
Alto Neuroscience, Inc.cik:0001999480
Revision history · 0
No field has changed since this record was first ingested.
